BioPortfolio - sanofi-synthelabo

Download PDF PDF Version
Email profile changes
Upgrade this profile
Add a new company

Contact Details:
	leeg. 3-3
	Vienna
	Vienna
	A-1140
	Austria
Tel:	^8941286
Fax:
Email:
WWW:	www.synthelabo.fr/

Recent Publications by sanofi-synthelabo:
Repression of cell cycle-related proteins by oxaliplatin but not cisplatin in human colon cancer cells. Oxaliplatin (Eloxatin) is a third-generation platinum derivative with an...	9th December, 2006	Oncology Department, Sanofi-Synthelabo Recherche, F-34184 Montpellier	Mol Cancer Ther. 2006 Sep;5(9):2149-57. DOI Direct Link
Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance. The aim of this study was to compare the relative bioavailability and the...	9th December, 2006	Sanofi-Synthelabo Research (Sanofi-Aventis group), Chilly-Mazarin, France.	Fundam Clin Pharmacol. 2006 Aug;20(4):397-403. DOI Direct Link
Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Neuropilin 2 (NRP2) is a receptor for the vascular endothelial growth...	13th September, 2006	Angiogenesis and Thrombosis Department, Sanofi-Synthelabo Research, 31036	Blood. 2006 Aug 15;108(4):1243-50. Epub 2006 Apr 18. DOI Direct Link
[Arterial hypertension in obese patients. Rationale for a prospective medical care study in the family doctor's practice] Patients with high blood pressure are often overweight or even obese....	5th August, 2006	Institut fur Klinische Pharmakologie, Medizinische Fakultat, TU Dresden,	MMW Fortschr Med. 2004 Aug 5;146 Suppl 2:45-50.
Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats. Despite the well-documented effect of irbesartan, an angiotensin AT1...	8th June, 2006	Cardiovascular Research Department, Sanofi-Synthelabo Research, 1 Avenue	Eur J Pharmacol. 2006 Mar 18;534(1-3):271-9. Epub 2006 Mar 6. DOI Direct Link
→View more sanofi-synthelabo research publications.

BioNews Results for sanofi-synthelabo:
Clearing the Obstacles to Evidence-based ACS Care: New Strategies to Guide Practitioners	Medscape: Jun 27 2008 8:07PM Matching: sanofi synthelabo
LILLY (ELI) & COMPANY: FDA Extends Review Period for Prasugrel	FinanzNachrichten.de: Jun 24 2008 1:01PM Matching: sanofi synthelabo
FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel	Business Journal of Milwaukee: Jun 24 2008 12:32AM Matching: sanofi synthelabo
FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel	Twin Cities Business Journal: Jun 23 2008 11:39PM Matching: sanofi synthelabo
FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel	The Business Journal Phoenix: Jun 23 2008 11:32PM Matching: sanofi synthelabo
Promote your company here: BioNewsCast - Press Release Distribution	→View more sanofi-synthelabo news.

sanofi-synthelabo Patents:
US Patent No.	Title
6573381	Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates
6642233	1-Phenacyl-3-phenyl-3-(piperidylethyl)piperidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
6642258	Use of central cannabinoid receptor antagonist for preparing medicines
6649627	Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
6670338	Pentasaccharides processes for their preparation and pharmaceutical compositions containing them
→View more sanofi-synthelabo patents.

sanofi-synthelabo (SNY) Financial information Links from Barchart
SNY Quote from from Barchart.com
SNY Chart from from Barchart.com
SNY Profile from from Barchart.com
SNY Opinion from from Barchart.com
→View more sanofi-synthelabo finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 65 individuals from sanofi-synthelabo using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 309 times since April 2007, the link to the organisation's website has been followed 76 times

Search for more companies in Vienna

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for sanofi-synthelabo

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.

sanofi-synthelabo

Recent Publications by sanofi-synthelabo:

BioNews Results for sanofi-synthelabo:

sanofi-synthelabo Patents:

sanofi-synthelabo (SNY) Financial information Links from Barchart